UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Care close to home: how a rural doctor meets medical needs in Alabama’s countryside
Doctors are harder to come by in rural Alabama than in big cities. That’s why Cahaba Medical Care developed a residency program that both trains and then hires doctors in rural clinics.
Federal judge orders Jefferson County to redraw racially gerrymandered districts
U.S. District Judge Madeline H. Haikala ruled the county map was unconstitutional because race was the predominant factor when the Jefferson County Commission drew districts.
To save its unique and rare birds, New Zealand is turning to AI and genetic research
New Zealand is planning to eradicate millions of invasive animals that prey on the country's rare birds. The goal may not be possible, unless new technology can be developed to do it.
Why beef prices are higher than ever (and shoppers are finally resisting)
American ranchers are raising the fewest cows in decades. Through the price increases, American shoppers have stayed loyal to their love of burgers and steaks — until now.
What does the Google antitrust ruling mean for the future of AI?
A federal judge's mild ruling in the Justice Department's suit over Google's search engine monopoly has critics worried that the tech giant can now monopolize artificial intelligence.
Trump is deploying the National Guard to Memphis. Experts worry it’s becoming normal
The president signed an order earlier this week to send Tennessee state National Guard troops, along with officials from various federal departments and agencies, into Memphis, in an effort to fight crime. It's one of several U.S. cities Trump has singled out for such a move, testing the limits of presidential power and military force.
